Biggest Nursing Home Company Accused of Cutting Corners on Patient Care
Hunterbrook report accuses Ensign Group of understaffing, gaming metrics, and patient neglect.
Hunterbrook report accuses Ensign Group of understaffing, gaming metrics, and patient neglect.
Raymond James reiterates Strong Buy rating and $68 target on Liquidia after the Supreme Court’s positive Hikma v. Amarin decision.
At ASCO 2026, Grail’s Galleri multi-cancer blood test showed promise but missed its main goal in the large NHS trial. Experts say it’s not ready for broad population screening yet.
Lantheus is in talks to be bought by Curium for about $7B. No deal yet. Stock rose. Deal would be big in nuclear medicine.
Elliott bought into Bio-Rad to boost its weak stock, betting on turnaround and its valuable Sartorius stake driving future growth.
Moderna stock rises as it works on a hantavirus vaccine after a cruise outbreak, but the disease is rare and vaccines will take years.